bims-ensmum Biomed News
on Exercise and nutrition in skeletal muscle metabolism
Issue of 2026–09–27
five papers selected by
Rachel M. Handy, University of Guelph and Universiteit Mastricht



  1. J Appl Physiol (1985). 2026 Sep 21.
      Infrared radiation (IR) has previously been demonstrated to activate signalling pathways involved in mitochondrial biogenesis and angiogenesis. We tested the hypothesis that IR emitting fabric (IREF) would enhance translocation and phosphorylation of proteins, and mRNA expression of genes, associated with mitochondrial biogenesis and angiogenesis in response to high-intensity interval exercise (HIIE) compared to non-IREF. Eleven males (age, 22 ± 4 yrs, V̇O2peak, 48.0 ± 4.6 ml·kg-1·min-1) completed two HIIE sessions consisting of 10 x 3 min intervals at a power output equivalent to 60% of the difference between gas exchange threshold and peak power output. Each interval was interspersed by 3 min at 25 W. In a repeated-measures, counter balanced, single-blind design, participants wore IREF and non-IREF clothing (SHAM) before, during and following HIIE. Muscle biopsies were obtained pre (Baseline), immediately post (PE) and 3 hours post exercise (3hPE). Cytosolic and Nuclear p-CaMKII content were both greater PE in IREF compared to SHAM (P = 0.001 and P = 0.003 respectively). Cytosolic and Nuclear p-p38 MAPK content increased from baseline to PE in IREF (P = 0.008 and P = 0.005, respectively) but not SHAM. NRF1 and TP53 mRNA expression were greater in IREF compared to SHAM PE (P ≤ 0.013) and 3hPE in NRF1 only (P = 0.002). There was no change in the phosphorylated protein content or gene expression of any angiogenesis related target in IREF compared to SHAM. Wearing IREF before, during and following HIIE augments some of the acute cellular signalling cascades associated with mitochondrial biogenesis.
    Keywords:  Angiogenesis; Gene expression; Mitochondrial biogenesis; Protein phosphorylation; Skeletal muscle adaptation
    DOI:  https://doi.org/10.1152/japplphysiol.00258.2026
  2. bioRxiv. 2026 Sep 17. pii: 2026.09.15.751463. [Epub ahead of print]
      Reactive oxygen species (ROS) regulate protein function through reversible cysteine oxidation. In human skeletal muscle, exercise-induced ROS initiates adaptations such as mitochondrial biogenesis, increased insulin sensitivity, and hypertrophy. However, specific protein targets of ROS regulation during exercise remain unclear owing to longstanding challenges in analyzing redox proteomes in vivo . We applied cysteine derivatization and multiplexed proteomics to map muscle protein cysteine oxidation in humans during exercise. The OxiMuscle dataset quantifies reversible modifications across 9,177 unique cysteine sites on 2,782 proteins, comprising 17,492 individual cysteine site measurements in young men undergoing three types of exercise, providing the first comprehensive, site-resolved and quantitative analysis of the exercise-regulated redox cysteine proteome in humans. We systematically define cysteine oxidation targets regulated by at least one form of exercise, many of which reside in proteins with established roles in muscle physiology. Among these sites is a redox-regulated cysteine on the autophagy receptor protein p62. We demonstrate that reversible oxidation of this cysteine regulates p62-mediated autophagy upon myotube contraction and mouse muscle adaptation to exercise in vivo . Together, these results define a redox-driven mechanism linking exercise-induced autophagy to muscle adaptation. More broadly, our findings offer a comprehensive resource on redox-signaling networks in human muscle, accessible at http://oximuscle-alb-1899330623.us-east-1.elb.amazonaws.com/ .
    DOI:  https://doi.org/10.64898/2026.09.15.751463
  3. Scand J Med Sci Sports. 2026 Oct;36(10): e70373
      Sodium bicarbonate (SB) ingestion may improve high-intensity exercise performance in efforts that range from 1 to 60 min; however, to date, no studies have investigated the effects of SB supplementation during exercise, nor its potential to attenuate the fatigue-induced decline in parameters of the power-duration curve during prolonged exercise (i.e., durability). This study examined the effects of bicarbonate (BI) and carbohydrate (CHO) co-ingestion via a novel gel format during exercise on subsequent sprint and time-trial (TT) performance in cyclists. Eleven trained cyclists took part in this randomized, crossover study. Following one visit to establish a non-fatigued power profile (3 × 6-s sprints, 2-min TT and 12-min TT cycling performance), participants completed two experimental trials consisting of 3 h cycling at 95% gas exchange threshold and ingested CHO at a rate of 80 g·h-1 with (CHO + BI; 18 g of SB and 2 g of potassium bicarbonate) or without BI co-ingestion (CHO). Participants repeated the same power profiling protocol after the 3 h submaximal exercise. Performance in the 12-min TT was improved in the CHO + BI condition compared with CHO (+12 W; p = 0.01, g = 1.07). Mean power output in the 6-s sprints (+12 W; p = 1.00, g = 0.18) and 2-min TT (+6 W; p = 0.888, g = 0.32) were not significantly different between CHO + BI and CHO. There were no differences in gastrointestinal symptoms between conditions. These data suggest that BI and CHO co-ingestion during prolonged exercise via a novel energy gel format improves subsequent 12-min TT performance in a fatigued state with minimal gastrointestinal discomfort.
    Keywords:  acid–base balance; durability; endurance; ergogenic aid; fatigue resistance; nutrition; physiological resilience; power‐duration relationship
    DOI:  https://doi.org/10.1111/sms.70373
  4. J Physiol. 2026 Sep 25.
      Ageing and disuse are two of the most clinically relevant conditions associated with the loss of skeletal muscle mass, yet the ultrastructural adaptations that drive these losses remain poorly defined. Indeed, even the most basic questions, such as whether radial atrophy of muscle fibres is driven primarily by reductions in myofibril size, and/or the loss of myofibrils, remain unanswered. To address this gap, skeletal muscle structure was assessed at the macroscopic, microscopic and ultrastructural levels in young and older humans and mice. In humans, magnetic resonance imaging was used to measure quadriceps muscle volume and cross-sectional area (CSA), whereas vastus lateralis biopsies underwent standard immunohistochemistry for microscopic evaluations, coupled with a next-generation fluorescence imaging pipeline for ultrastructural analyses. Parallel experiments were conducted in mice, including a unilateral immobilization model of disuse-induced atrophy. Ageing in humans was associated with lower muscle volume and CSA, along with radial atrophy of SERCA1-positive fibres, whereas SERCA2-positive fibre CSA was preserved. Notably, the radial atrophy of SERCA1 fibres was largely explained by a lower number of myofibrils, rather than a smaller size of the myofibrils. Similar alterations were observed in aged mice, although SERCA1 fibres also exhibited slightly smaller myofibril size. In mice, disuse likewise caused radial muscle fibre atrophy that was again almost exclusively associated with a lower number of myofibrils. Collectively, these findings identify the loss of myofibrils as a central and conserved mechanism that mediates radial muscle fibre atrophy during ageing and disuse, highlighting a potential therapeutic target for preserving skeletal muscle mass. KEY POINTS: Skeletal muscles atrophy with ageing and disuse, and the loss of muscle mass increases the risk of falls, disability and all-cause mortality. Skeletal muscles are composed of long cells called muscle fibres, and each fibre is densely packed with thread-like structures called myofibrils; however, whether muscle fibre atrophy is primarily driven by reductions in the size of the myofibrils, and/or the loss of myofibrils, is not known. Using a next-generation imaging pipeline, this study examined muscle samples from young and older adults, as well as from young and old mice. The results show that muscle fibre atrophy during both ageing and disuse is mainly associated with a lower number of myofibrils, rather than a smaller size of the myofibrils. Identifying the loss of myofibrils as the primary mechanism underlying muscle fibre atrophy highlights a specific therapeutic target for preserving muscle as people age or recover from injury.
    Keywords:  FIM‐ID; atrophy; immobilization; muscle fibre; myofibrils; sarcopenia
    DOI:  https://doi.org/10.1113/JP291728
  5. Diabetes Obes Metab. 2026 Sep 20.
       AIMS: To assess the effect of semaglutide on body composition and physical function.
    MATERIALS AND METHODS: The phase 3b STEP UP trial randomised adults with body mass index ≥ 30 kg/m2 to once-weekly subcutaneous semaglutide 7.2 mg, semaglutide 2.4 mg or placebo for 72 weeks. This prespecified secondary analysis assessed changes in MRI body composition and physical function.
    RESULTS: Of 1407 participants, 55 with a valid baseline scan were included (semaglutide 7.2 mg, n = 43, 2.4 mg, n = 6 [pooled semaglutide group, n = 49]; placebo, n = 6). Estimated treatment differences (95% confidence intervals; p-values) for absolute changes in adipose/muscle compartment volumes for the pooled semaglutide versus placebo group, respectively, were: -11.1 L (-16.5 to -5.7; p < 0.0001) for adipose body tissue, -1.5 L (-2.9 to -0.1; p = 0.04) for visceral adipose tissue, -1.7 L (-4.0 to 0.7; p = 0.16) for lean body tissue, -1.1 L (-2.3 to 0.1; p = 0.07) for thigh skeletal muscle volume and -0.92%-points (-1.41 to -0.42; p = 0.001) for thigh muscle fat infiltration. Similar results were seen for relative changes in adipose/muscle compartment volumes. A sensitivity analysis for the semaglutide 7.2 mg group versus placebo showed similar results. A mean of 13 sit-to-stand repetitions in 30 s at baseline, and 15 repetitions at Week 72, was observed in the pooled semaglutide and placebo groups.
    CONCLUSIONS: Semaglutide plus lifestyle intervention was associated with reductions in adipose tissue volume, skeletal muscle volume and skeletal muscle fat infiltration, with a preserved number of sit-to-stand repetitions. Further research to assess the impact of weight loss on skeletal muscle composition and function should be explored in the future.
    TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT05646706.
    Keywords:  GLP‐1 analog; antiobesity drug; clinical trial; randomised trial; semaglutide; weight management
    DOI:  https://doi.org/10.1111/dom.71323